BiotechTube

dabigatran etexilate + rivaroxaban

Phase 1Completed
0 watching 0 views this week💤 Quiet
33
Hype Score

Development Stage

✓
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Thrombosis

Conditions

Thrombosis

Trial Timeline

May 1, 2011 → Dec 1, 2011

NCT ID
NCT01379300

About dabigatran etexilate + rivaroxaban

dabigatran etexilate + rivaroxaban is a phase 1 stage product being developed by Merck for Thrombosis. The current trial status is completed. This product is registered under clinical trial identifier NCT01379300. Target conditions include Thrombosis.

Hype Score Breakdown

Clinical
10
Activity
5
Company
10
Novelty
3
Community
2

Clinical Trials (1)

NCT IDPhaseStatus
NCT01379300Phase 1Completed

Competing Products

20 competing products in Thrombosis

See all competitors
ProductCompanyStageHype Score
CS1-Sodium ValproateCereno ScientificPhase 1
28
Edoxaban low dose + Edoxaban high doseDaiichi SankyoPhase 1
33
DU176b - action is the prevention of venous thromboembolism by the use of a Factor Xa inhibitorDaiichi SankyoPhase 2
52
edoxaban tosylate + enoxaparin/unfractionated heparin + warfarinDaiichi SankyoPhase 2
52
Rivaroxaban (Xarelto, BAY59-7939)Johnson & JohnsonPhase 2
52
Warfarin (Coumadin) + Rivaroxaban (Xarelto, BAY59-7939) + Placebo + Vitamin K (Konakion)Johnson & JohnsonPhase 1
33
Rivaroxaban (Xarelto, BAY59-7939) + Enoxaparin followed by VKAJohnson & JohnsonPhase 3
77
SHR2285 tablet + PlaceboJiangsu Hengrui MedicinePhase 1
33
SHR2285 + PlaceboJiangsu Hengrui MedicinePhase 1
33
Aspirin、clopidogrel、placebo or SHR2285 + Aspirin、clopidogrel、placebo or SHR2285 + Aspirin、ticagrelor、placebo or SHR2285Jiangsu Hengrui MedicinePhase 1
33
Rosuvastatin (AZD4522) + PlaceboAstraZenecaPhase 3
77
MK-2060 + PlaceboMerckPhase 1
33
Alteplase "push" protocol + alteplase dwell armRocheApproved
85
Apixaban IR + Apixaban MR1 + Apixaban MR2 + Apixaban MR3PfizerPhase 1
32
Enoxaparin + warfarin + Placebo for apixaban + Placebo for enoxaparin + Placebo for warfarin + apixabanPfizerPhase 3
76
Apixaban + PlaceboPfizerPhase 3
76
90ug levonorgestrel / 20 ug ethinyl estradiol + Oral Contraceptives containing 20 ug of ethinyl estradiolPfizerPre-clinical
22
Fragmin (dalteparin sodium )PfizerPre-clinical
22
PD 0348292 + EnoxaparinPfizerPhase 2
51
Dalteparin + WarfarinPfizerPhase 2
51

Other Products from Merck

DuleraApproved
85
ImipenemApproved
85
Mavenclad®Approved
85
raltegravir + PlaceboApproved
85
alendronate sodiumApproved
85